Novo Nordisk's Stock Prices Decline Amid FDA Concerns Over Clayton Plant Manufacturing Issues
(CTN News) - Novo Nordisk's stock prices continued to decline on Tuesday following reports that the FDA had recently raised concerns about manufacturing
Source: chiangraitimes.com